OptiBiotix double finalist success in Nutraingredients awards

OptiBiotix Health Plc (OptiBiotix), a life sciences company that develops compounds to tackle obesity, high cholesterol and diabetes, has been shortlisted as a finalist in two NutraIngredients Awards categories in recognition of its microbiome modulating products.

The company’s natural heart health solution, LPLDL®, is a finalist in the ‘Probiotic Product of the Year’ category and its sustainable weight management system, SlimBiome®, is a finalist in the ‘Ingredient of the Year: Weight Management’ category.

Stephen O’Hara, OptiBiotix CEO, said: “We are thrilled to receive this double shortlisting, which provides independent industry acknowledgement of the scientific innovation behind LPLDL® and SlimBiome®. Both products offer ground-breaking value to the nutraceutical sector and we welcome the NutraIngredients Awards’ celebration of this.”

LPLDL® is a probiotic product which uses a naturally occurring bacterial strain, Lactobacillus plantarum, to reduce cholesterol and control high blood pressure. Independent human studies have shown LPLDL® to be safe and able to reduce total cholesterol by up to 36 per cent in some patients.

SlimBiome® is a healthy, hunger-free system formulated by world experts in satiation and the microbiome. Unlike many existing weight management products which typically depend on calorie restriction and willpower alone, this product uses a patented combination of natural ingredients to harness the power of the microbiome and take the hassle out of slimming.

Due to be held at the Vitafoods Europe event in Geneva, the NutraIngredients Awards recognise the creativity and innovation that is forging the future of the nutraceutical industry. The winners will be announced at a glittering awards dinner on 16 May 2018, celebrating the top developments made by the sector’s most influential companies.